Caitlin Reichert studied Life Sciences at the Hogeschool Utrecht, graduating in July 2021. She performed her final internship in the Den Boer group, investigating the characteristics of the leukemic microenvironment together with dr. Cesca van de Ven. Subsequently, she became a research technician within the Den Boer group.
As a technician she has contributed to the groups research, including drug sensitivity tests, personalized medicine, and projects involving BCR-ABL1 positive and ABL-class B-cell precursor acute lymphoblastic leukemia (BCP-ALL). She currently focusses on the effect of the leukemic microenvironment on the response to CAR-T based immunotherapy, to optimize immunotherapy efficacy for children with BCP-ALL.
Phone 088 97 25 071